Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kyntra Bio (KYNB) Return on Assets (2016 - 2025)

Historic Return on Assets for Kyntra Bio (KYNB) over the last 11 years, with Q3 2025 value amounting to 1.7%.

  • Kyntra Bio's Return on Assets rose 17500.0% to 1.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.7%, marking a year-over-year increase of 17500.0%. This contributed to the annual value of 0.33% for FY2024, which is 2600.0% up from last year.
  • Per Kyntra Bio's latest filing, its Return on Assets stood at 1.7% for Q3 2025, which was up 17500.0% from 0.5% recorded in Q2 2025.
  • Kyntra Bio's Return on Assets' 5-year high stood at 1.7% during Q3 2025, with a 5-year trough of 0.73% in Q4 2023.
  • In the last 5 years, Kyntra Bio's Return on Assets had a median value of 0.33% in 2024 and averaged 0.16%.
  • As far as peak fluctuations go, Kyntra Bio's Return on Assets plummeted by -3100bps in 2023, and later soared by 17500bps in 2025.
  • Over the past 5 years, Kyntra Bio's Return on Assets (Quarter) stood at 0.36% in 2021, then crashed by -35bps to 0.48% in 2022, then tumbled by -51bps to 0.73% in 2023, then skyrocketed by 160bps to 0.44% in 2024, then skyrocketed by 286bps to 1.7% in 2025.
  • Its last three reported values are 1.7% in Q3 2025, 0.5% for Q2 2025, and 0.58% during Q1 2025.